Table 1.
First Admission | Follow up at Last Contact, #, & | ||||||||
---|---|---|---|---|---|---|---|---|---|
Gender | Age | LVEDD (z-Score) | EF (%) |
BNP (pg/mL) |
Age | LVEDD (z-Score) | EF (%) |
BNP (pg/mL) | |
A.III.3 | female | 2 y | +7.2 | severely reduced | 6528 | # at the age of 2 y | # | # | # |
A.III.2 | male | 0 m | +2.2 | normal | 206 | # at the age of 13 y | # | # | # |
A.III.1 | male | 6 m | −0.9 | 64 | n.a. | 5 y | +3.9 | 66 | n.a. |
B. II.3 | male | n.a. | n.a. | n.a. | n.a. | & at the age 50 y | & | & | & |
B.III.3 | male | 5 m | +8.4 | reduced | n.a. | # at the age of 8 m, & at the age of 12 y |
& | & | & |
B.III.4 | male | 12 y | 7.7 | severely reduced | n.a. | & at the age 12 y | & | & | & |
B.III.5 | female | 10 y | 1.5 | mildly reduced | n.a. | # at the age of 14 y, & at the age of 20 y | & | & | & |
B.III.6 | male | 21 m | −0.4 | normal | n.a. | 12 y | +1.0 | 51 | <50 |
C.II.1 | female | 4 y | +4.6 | 25 | 3651 | 12 y | +4.6 | 48 | 59 |
C.II.2 | female | 14 y | +5.1 | 62 | n.a. | 16 y | +4.8 | 48 | 29 |
C.I.2 | female | 35 y | n.a. | n.a. | n.a. | 39 y | +5.2 | n.a. | n.a. |
EF—ejection fraction; LVEDD—left ventricular end diastolic diameter; m—months; y—years. #—patient was heart transplanted, &—patient died.